🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

US STOCKS-Wall St set to dip as monthly private payrolls disappoint

Published 12/02/2020, 09:58 PM
Updated 12/02/2020, 10:00 PM
© Reuters.
NTAP
-
BNTX
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Pfizer, BioNTech rise on getting UK approval for vaccine
* Salesforce drops on $27.7 bln deal to buy Slack
Technologies
* NetApp gains on upbeat profit forecast
* Futures: Dow and Nasdaq down 0.4% each, S&P down 0.3%

(Adds comment, details; updates prices)
By Medha Singh and Susan Mathew
Dec 2 (Reuters) - The S&P 500 and the Nasdaq were set to
ease on Wednesday from record levels hit in the previous session
as data showing fewer-than-expected private job additions in
November added to concerns about the near-term pressure on the
economy.
The ADP data is the latest sign that soaring new infections
and business restrictions are hampering the labor market's
recovery. The more crucial employment report is expected on
Friday. Positive updates on coronavirus vaccine have helped
investors raise bets on a swift economic rebound next year,
powering the Wall Street's main indexes to life-highs recently.
Pfizer Inc PFE.N and BioNTech's BNTX.O COVID-19 vaccine
got the green light for use in Britain, the first Western
country to approve a shot for COVID-19. Pfizer rose 3.3% and
BioNTech added 5%. "It's great news for Pfizer to be able to monetize it
earlier (but) approval in one country would not really see a
broader impact on markets," said Ingo Schachel, head of equity
research at Commerzbank, Germany.
"After a few days of strong equity market performance, it's
moderate profit taking."
Meanwhile, U.S. officials on Monday unveiled details of
their plan to distribute vaccines to millions of Americans
starting later this month. At 08:33 a.m. ET, Dow E-minis 1YMcv1 fell 121 points, or
0.41%, S&P 500 E-minis EScv1 dropped 10.75 points, or 0.29%.
Nasdaq 100 E-minis NQcv1 declined 51.25 points, or 0.41%.
Investors are keen on progress in stimulus talks after a
bipartisan group of U.S. senators and House of Representative
members proposed a $908 billion relief bill on Tuesday.
Getting a generous stimulus package through Congress is a
top priority, Joe Biden said in an interview with the New York
Times. The President-elect also said he would not immediately
cancel the Phase 1 trade deal that President Donald Trump struck
with China. Among individual stocks, Salesforce.com Inc CRM.N shed
about 6% as it agreed to buy workplace messaging app Slack
Technologies Inc WORK.N in a $27.7 billion deal as it bets on
an extended run for remote working. Cloud data service provider NetApp's shares NTAP.O jumped
7.5% after it provided current quarter profit above expectations
after topping estimates in the second quarter.
Later in the day, investors will turn to the Federal
Reserve's Beige Book report, a glimpse of the economy based on
conversations with business contacts.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.